Inflammasome activation and IL-1β and IL-18 processing during infection

Trends in Immunology

Volumn 32, Issue 3, 2011, Pages 110-116

  van de Veerdonk, Frank L ^a   Netea, Mihai G ^a   Dinarello, Charles A ^a,b   Joosten, Leo A B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PATTERN RECOGNITION RECEPTOR; SERINE PROTEINASE;

ADAPTIVE IMMUNITY; APOPTOSIS; CELL TYPE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVATION; ENZYME ACTIVITY; HOST RESISTANCE; HUMAN; INFECTION; MONOCYTE; NEUTROPHIL; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN SECRETION; REVIEW; T LYMPHOCYTE; TH1 CELL; TH17 CELL;

ANIMALS; HUMANS; INFECTION; INFLAMMATION; INTERLEUKIN-18; INTERLEUKIN-1BETA; T-LYMPHOCYTES;

EID: 79952102031     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2011.01.003     Document Type: Review

References (77)

1. Marodi L., et al. Mechanisms of host defense against Candida species. 1. Phagocytosis by monocytes and monocyte-derived macrophages. J. Immunol. 1991, 146:2783-2789.
2. Taylor P.R., et al. Macrophage receptors and immune recognition. Annu. Rev. Immunol. 2005, 23:901-944.
3. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
4. Dinarello C.A. IL-18: a Th1-inducing, proinflammatory cytokine and a new member of the IL-1 family. J. Allergy Clin. Immunol. 1999, 103:11-24.
5. Latz E. The inflammasomes: mechanisms of activation and function. Curr. Opin. Immunol. 2010, 22:28-33.
6. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
7. Martinon F., et al. Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr. Biol. 2004, 14:1929-1934.
8. Kanneganti T.D., et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006, 440:233-236.
9. Mariathasan S., et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440:228-232.
10. Eisenbarth S.C., et al. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008, 453:1122-1126.
11. Dostert C., et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science (New York, N.Y.) 2008, 320:674-677.
12. Franchi L., et al. Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J. Immunol. 2009, 183:792-796.
13. Bauernfeind F.G., et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 2009, 183:787-791.
14. Kanneganti T.D., et al. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 2007, 26:433-443.
15. Halle A., et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 2008, 9:857-865.
16. Hornung V., et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 2008, 9:847-856.
17. Faustin B., et al. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol. Cell 2007, 25:713-724.
18. Hsu L.C., et al. A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:7803-7808.
19. Franchi L., et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat. Immunol. 2006, 7:576-582.
20. Miao E.A., et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat. Immunol. 2006, 7:569-575.
21. Miao E.A., et al. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:3076-3080.
22. Lightfield K.L., et al. Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin. Nat. Immunol. 2008, 9:1171-1178.
23. Miao E.A., et al. Pseudomonas aeruginosa activates caspase 1 through Ipaf. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:2562-2567.
24. Sutterwala F.S., et al. Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J. Exp. Med. 2007, 204:3235-3245.
25. Suzuki T., Nunez G. A role for Nod-like receptors in autophagy induced by Shigella infection. Autophagy 2008, 4:73-75.
26. Hornung V., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458:514-518.
27. Fernandes-Alnemri T., et al. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009, 458:509-513.
28. Dinarello C.A., et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-1. J. Exp. Med. 1986, 163:1433-1450.
29. Dinarello C.A., et al. Interleukin 1 induces interleukin 1. I. Induction of interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. J. Immunol. 1987, 139:1902-1910.
30. Netea M.G., et al. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 2009, 113:2324-2335.
31. Ferrari D., et al. Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 1997, 185:579-582.
32. Ferrari D., et al. The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol. 2006, 176:3877-3883.
33. Elssner A., et al. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J. Immunol. 2004, 172:4987-4994.
34. Emre Y., et al. Mitochondria contribute to LPS-induced MAPK activation via uncoupling protein UCP2 in macrophages. Biochem. J. 2007, 402:271-278.
35. Meissner F., et al. Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease. Blood 2010, 116:1570-1573.
36. van de Veerdonk F.L., et al. Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:3030-3033.
37. van Bruggen R., et al. Human NLRP3 inflammasome activation is Nox1-4 independent. Blood 2010, 115:5398-5400.
38. Meissner F., et al. Superoxide dismutase 1 regulates caspase-1 and endotoxic shock. Nat. Immunol. 2008, 9:866-872.
39. Zhou R., et al. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.
40. Ottenhoff T.H., et al. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat. Genet. 2002, 32:97-105.
41. Veldhoen M., et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
42. Sutton C.E., et al. Interleukin-1 and IL-23 induce innate IL-17 production from γδT cells, amplifying Th17 responses and autoimmunity. Immunity 2009, 31:331-341.
43. Chung Y., et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 2009, 30:576-587.
44. Reznikov L.L., et al. IL-18 binding protein increases spontaneous and IL-1-induced prostaglandin production via inhibition of IFN-γ. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:2174-2179.
45. Lee J.K., et al. Differences in signaling pathways by IL-1beta and IL-18. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:8815-8820.
46. Hou W., et al. Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J. Exp. Med. 2009, 206:313-328.
47. Stumhofer J.S., et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 2006, 7:937-945.
48. Sansonetti P.J., et al. Caspase-1 activation of IL-1β and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity 2000, 12:581-590.
49. Mariathasan S., et al. Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J. Exp. Med. 2005, 202:1043-1049.
50. Tsuji N.M., et al. Roles of caspase-1 in Listeria infection in mice. Int. Immunol. 2004, 16:335-343.
51. Ichinohe T., et al. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 2009, 206:79-87.
52. Allen I.C., et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009, 30:556-565.
53. Hise A.G., et al. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 2009, 5:487-497.
54. Gross O., et al. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 2009, 459:433-436.
55. Mencacci A., et al. Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1-deficient mice. Infect. Immun. 2000, 68:5126-5131.
56. Said-Sadier N., et al. Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS production and the Syk tyrosine kinase. PLoS ONE 2010, 5:e10008.
57. McElvania Tekippe E., et al. Granuloma formation and host defense in chronic Mycobacterium tuberculosis infection requires PYCARD/ASC but not NLRP3 or caspase-1. PLoS ONE 2010, 5:e0012320.
58. Mayer-Barber K.D., et al. Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 2010, 184:3326-3330.
59. Reimer T., et al. Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome. Eur. J. Immunol. 2010, 40:764-769.
60. Shio M.T., et al. Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog. 2009, 5:e1000559.
61. Dostert C., et al. Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS ONE 2009, 4:e6510.
62. Fantuzzi G., et al. Response to local inflammation of IL-1 beta-converting enzyme- deficient mice. J. Immunol. 1997, 158:1818-1824.
63. Horai R., et al. Production of mice deficient in genes for interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 receptor antagonist shows that IL-1β is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 1998, 187:1463-1475.
64. Cheng W., et al. Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection. Infect. Immun. 2008, 76:515-522.
65. Prantner D., et al. Critical role for interleukin-1beta (IL-1β) during Chlamydia muridarum genital infection and bacterial replication-independent secretion of IL-1β in mouse macrophages. Infect. Immun. 2009, 77:5334-5346.
66. Coeshott C., et al. Converting enzyme-independent release of tumor necrosis factor α and IL-1β from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:6261-6266.
67. Schonbeck U., et al. Generation of biologically active IL-1β by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1β processing. J. Immunol. 1998, 161:3340-3346.
68. Joosten L.A., et al. Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta. Arthritis Rheum. 2009, 60:3651-3662.
69. Ippagunta S.K., et al. Inflammasome-independent role of apoptosis-associated speck-like protein containing a CARD (ASC) in T cell priming is critical for collagen-induced arthritis. J. Biol. Chem. 2010, 285:12454-12462.
70. Guma M., et al. Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation. Arthritis Rheum. 2009, 60:3642-3650.
71. Fremond C.M., et al. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J. Immunol. 2007, 179:1178-1189.
72. Mencacci A., et al. Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1-deficient mice. Infect. Immun. 2000, 68:5126-5131.
73. Hasegawa M., et al. Mechanism and repertoire of ASC-mediated gene expression. J. Immunol. 2009, 182:7655-7662.
74. Sarkar A., et al. ASC directs NF-κB activation by regulating receptor interacting protein-2 (RIP2) caspase-1 interactions. J. Immunol. 2006, 176:4979-4986.
75. Sugawara S., et al. Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J. Immunol. 2001, 167:6568-6575.
76. Omoto Y., et al. Human mast cell chymase cleaves pro-IL-18 and generates a novel and biologically active IL-18 fragment. J. Immunol. 2006, 177:8315-8319.
77. Omoto Y., et al. Granzyme B is a novel interleukin-18 converting enzyme. J. Dermatol. Sci. 2010, 59:129-135.